Anti-melanoma activity of T cells redirected with a TCR-like chimeric antigen receptor-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-melanoma activity of T cells redirected with a TCR-like chimeric antigen receptor

Published:2014-01-06 Issue:1 Volume:4 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Zhang Ge,Wang Lei,Cui Honglian,Wang Xiaomin,Zhang Ganlin,Ma Juan,Han Huamin,He Wen,Wang Wei,Zhao Yunfeng,Liu Changzhen,Sun Meiyi,Gao Bin

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep03571.pdf

Reference35 articles.

1. Lesterhuis, W. J., Haanen, J. B. & Punt, C. J. Cancer immunotherapy--revisited. Nature reviews. Drug discovery 10, 591–600 (2011).

2. Flutter, B. & Gao, B. MHC class I antigen presentation--recently trimmed and well presented. Cellular and Molecular Immunology 1, 22–30 (2004).

3. Imai, S. et al. Development of an antibody proteomics system using a phage antibody library for efficient screening of biomarker proteins. Biomaterials 32, 162–169 (2011).

4. Barrow, C. et al. Tumor Antigen Expression in Melanoma Varies According to Antigen and Stage. Clinical Cancer Research 12, 764–771 (2006).

5. Kawakami, Y. et al. Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection. Proceedings of the National Academy of Sciences 91, 6458–6462 (1994).

Cited by 85 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Conditional CAR T cells with specificity to oncofetal glycosaminoglycans in solid tumors;2024-06-02

2. CAR-T-Cell-Based Cancer Immunotherapies: Potentials, Limitations, and Future Prospects;Journal of Clinical Medicine;2024-05-29

3. Advancements in CAR-T Therapy: A Comprehensive Review;Current Cancer Therapy Reviews;2024-05-22

4. Current Advancements in Anti-Cancer Chimeric Antigen Receptor T Cell Immunotherapy and How Nanotechnology May Change the Game;International Journal of Molecular Sciences;2024-05-14

5. The molecular perspective on the melanoma and genome engineering of T-cells in targeting therapy;Environmental Research;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3